What is CUSIP 29668H708?

CUSIP 29668H708 is the security identifier used in SEC filing datasets for EPIX - ESSA Pharma Inc. - Common Shares, no par value per share.

Who owns EPIX - ESSA Pharma Inc. - Common Shares, no par value per share based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

Security Snapshot

ESSA Pharma Inc. - Common Shares, no par value per share (EPIX) Institutional Ownership

CUSIP: 29668H708

13F Institutional Holders and Ownership History from Q2 2018 to Q4 2025

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

$0.21

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period

Security type / class: Equity / Common Shares, no par value per share
Symbol: EPIX
Shares outstanding: 47,601,550
SEC-reported price per share: $0.21
Insider filing price: $0.21

13F Shares, Excluding Options vs Price

13F Value, Excluding Options

Total Investors

Key facts

EPIX - ESSA Pharma Inc. - Common Shares, no par value per share is tracked under CUSIP 29668H708.
Latest finished 13F holder period is not available.
4 significant owners is listed from Schedule 13D/13G reporting.

Change

Holder count moved from 32 to 0 between Q3 2025 and Q4 2025.
SEC-reported value moved from $4,301,583 to $0.

Research use

You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

29668H708

Latest holder period

n/a

13F holders

13D/G owners

CIK / CUSIP context first

EPIX full holder history

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

Recent Quarterly Holder Reports

Open recent reporting periods for CUSIP 29668H708:

Q4 2025 (0 holders) Q3 2025 (32 holders) Q2 2025 (35 holders) Q1 2025 (35 holders) Q4 2024 (44 holders) Q3 2024 (32 holders) Q2 2024 (31 holders) Q1 2024 (33 holders) Q4 2023 (31 holders) Q3 2023 (36 holders)

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows

Security

EPIX

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Soleus Capital Master Fund, L.P.	9.8%	+94%	$7,415,444	+$3,570,000	4,362,026	+93%	SOLEUS CAPITAL MASTER FUND, L.P.	17 Jul 2025
BML Investment Partners, L.P.	9.5%	+1.1%	$7,598,783	+$68,981	4,221,546	+0.92%	BML Investment Partners, L.P.	24 Apr 2025
MORGAN STANLEY	4%		$456,975		1,904,062		Morgan Stanley	30 Sep 2025
RTW INVESTMENTS, LP	2.5%		$2,003,404		1,113,002		RTW Investments, LP	31 Dec 2024

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods

Latest

n/a

Rows shown

1-25 of 31

Period	13F Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price (Median)	Investors
2025 Q4	0	$0	-$4,299,711	$0	$0	$0.21	0
2025 Q3	22,521,153	$4,301,583	-$19,774,211	$68,673	$81,288	$0.19	32
2025 Q2	30,970,782	$52,650,184	-$1,127,767	$341,530	$757,010	$1.70	35
2025 Q1	31,681,355	$50,056,171	-$2,246,323	$316	$66,834	$1.58	35
2024 Q4	32,829,217	$58,763,166	-$67,554,468	$27,029	$43,139	$1.79	44
2024 Q3	35,103,052	$212,724,662	+$269,717	$127,260	$95,748	$6.06	32
2024 Q2	35,208,390	$185,094,881	+$787,443	$19,988	$198,302	$5.26	31
2024 Q1	35,037,057	$297,463,581	+$2,481,095	$249,606	$453,366	$8.49	33
2023 Q4	34,772,388	$229,436,154	+$13,901,733	$133,980	$350,460	$6.60	31
2023 Q3	33,469,182	$103,416,891	+$681,859	$138,123	$26,574	$3.09	36
2023 Q2	33,249,423	$89,773,501	+$345,204	$71,280	$42,930	$2.70	38
2023 Q1	33,092,147	$98,277,629	+$349,180	$400,653	$257,202	$2.97	36
2022 Q4	33,368,813	$84,091,085	+$2,320,053	$216,216	$103,320	$2.52	43
2022 Q3	33,417,334	$60,814,684	-$15,060,697		$71,000	$1.82	49
2022 Q2	37,773,975	$118,994,687	-$275,773		$54,000	$3.15	55
2022 Q1	37,197,195	$229,891,130	-$37,768,183		$133,000	$6.18	66
2021 Q4	37,334,475	$530,072,278	+$7,512,573		$162,000	$14.20	58
2021 Q3	37,173,724	$297,437,064	-$67,533,896			$8.00	74
2021 Q2	34,155,853	$975,990,399	+$94,781,085			$28.57	78
2021 Q1	30,834,019	$895,742,171	+$247,196,452			$29.05	68
2020 Q4	23,117,706	$274,324,124	+$29,029,638			$11.93	38
2020 Q3	20,317,336	$139,156,228	+$43,178,452			$6.90	33
2020 Q2	14,061,425	$86,521,104	-$1,180,827			$6.20	19
2020 Q1	14,249,424	$56,595,712	+$1,185,503			$4.00	15
2019 Q4	13,929,616	$76,086,979	+$219,855			$5.50	18